From c548f73f3c3f2b82e32d829c29ab5b509adce269 Mon Sep 17 00:00:00 2001 From: "David A. Madore" Date: Sat, 23 May 2020 02:29:20 +0200 Subject: Link to study on (hydroxy)chloroquine. --- covid19-links.md | 10 ++++++++++ 1 file changed, 10 insertions(+) diff --git a/covid19-links.md b/covid19-links.md index 3917232..3016f84 100644 --- a/covid19-links.md +++ b/covid19-links.md @@ -87,6 +87,16 @@ ## Topical or time-specific links: ## +* [Hydroxychloroquine or chloroquine with or without a macrolide for + treatment of COVID-19: a multinational registry + analysis](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2820%2931180-6) + (2020-05-22, *The Lancet*). Key finding: were unable to confirm a + benefit of hydroxychloroquine or chloroquine, when used alone or + with a macrolide, on in-hospital outcomes for COVID-19. Each of + these drug regimens was associated with decreased in-hospital + survival and an increased frequency of ventricular arrhythmias when + used for treatment of COVID-19. + * [Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold](https://www.medrxiv.org/content/10.1101/2020.04.27.20081893v2) -- cgit v1.2.3